Clinical Trial

Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated June 18, 2023 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this research study is to explore the barriers encountered by specific demographic groups of rectal cancer patients during the engagement in clinical trials, which historically lack diverse representation. By carefully analyzing data from various demographic perspectives, this study aims to uncover patterns that impact the experiences of future rectal cancer patients. Active involvement in this crucial research is of utmost importance, as it can offer unique insights to enhance the participation and completion rates of rectal cancer patients in clinical study.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05910099
Lead Sponsor Power Life Sciences Inc.
Conditions Rectal Cancer
Enrollment 500 participants
Start Date 2024-07
Primary Completion 2025-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2023-06-18